olysio
janssen-cilag international nv - simeprevir - hepatitis c kronisk - antivirale midler til systemisk anvendelse - olysio er indiceret i kombination med andre lægemidler til behandling af kronisk hepatitis c (chc) hos voksne patienter. for at hepatitis c virus (hcv) genotype specifikke aktivitet.
quetiapin "accord" 200 mg depottabletter
accord healthcare b.v. - quetiapin fumarat - depottabletter - 200 mg
quetiapin "accord" 300 mg depottabletter
accord healthcare b.v. - quetiapin fumarat - depottabletter - 300 mg
quetiapin "accord" 400 mg depottabletter
accord healthcare b.v. - quetiapin fumarat - depottabletter - 400 mg
metoprololsuccinat "1a farma" 100 mg depottabletter
1a farma a/s - metoprololsuccinat - depottabletter - 100 mg
metoprololsuccinat "1a farma" 200 mg depottabletter
1a farma a/s - metoprololsuccinat - depottabletter - 200 mg
metoprololsuccinat "1a farma" 50 mg depottabletter
1a farma a/s - metoprololsuccinat - depottabletter - 50 mg
metoprololsuccinat "hexal" 100 mg depottabletter
hexal a/s - metoprololsuccinat - depottabletter - 100 mg
metoprololsuccinat "hexal" 200 mg depottabletter
hexal a/s - metoprololsuccinat - depottabletter - 200 mg
metoprololsuccinat "hexal" 50 mg depottabletter
hexal a/s - metoprololsuccinat - depottabletter - 50 mg